cilostazol has been researched along with Pregnancy in 7 studies
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cilostazol regimen, attenuated prenatal VPA exposure associated hyperlocomotion, social interaction deficits, repetitive behavior, and anxiety." | 8.02 | Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. ( Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP, 2021) |
| "Cilostazol (CLZ) is an FDA approved therapeutic that is indicated for patients with intermittent claudication disease." | 7.81 | Cilostazol blocks pregnancy in naturally cycling swine: An animal model. ( Ash, O; Fajt, V; Kraemer, DC; Muhsen-Alanssari, SA; Ridha-Albarzanchi, MT; Taiyeb, AM, 2015) |
| "Cilostazol (CLZ) is a PDE3A-I that is approved for medical indications in humans and has an additional effect of adenosine uptake inhibition that is believed to counterbalance the undesirable outcomes resulting from PDE inhibition." | 5.39 | Cilostazol blocks pregnancy in naturally cycling mice. ( Albarzanchi, AM; Dees, WL; Fajt, VR; Kraemer, DC; Ridha Albarzanchi, MT; Sayes, CM, 2013) |
| "The cilostazol regimen, attenuated prenatal VPA exposure associated hyperlocomotion, social interaction deficits, repetitive behavior, and anxiety." | 4.02 | Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. ( Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP, 2021) |
| "Cilostazol (CLZ) is an FDA approved therapeutic that is indicated for patients with intermittent claudication disease." | 3.81 | Cilostazol blocks pregnancy in naturally cycling swine: An animal model. ( Ash, O; Fajt, V; Kraemer, DC; Muhsen-Alanssari, SA; Ridha-Albarzanchi, MT; Taiyeb, AM, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Luhach, K | 1 |
| Kulkarni, GT | 1 |
| Singh, VP | 1 |
| Sharma, B | 1 |
| Taiyeb, AM | 2 |
| Muhsen-Alanssari, SA | 2 |
| Dees, WL | 2 |
| Ridha-Albarzanchi, MT | 2 |
| Kraemer, DC | 3 |
| Ash, O | 1 |
| Fajt, V | 1 |
| Li, M | 1 |
| Yu, Y | 1 |
| Yan, J | 1 |
| Yan, LY | 1 |
| Zhao, Y | 1 |
| Li, R | 1 |
| Liu, P | 1 |
| Hsueh, AJ | 1 |
| Qiao, J | 1 |
| Albarzanchi, AM | 1 |
| Sayes, CM | 1 |
| Ridha Albarzanchi, MT | 1 |
| Fajt, VR | 1 |
| Shintani, S | 1 |
| Watanabe, K | 1 |
| Kawamura, K | 1 |
| Mori, T | 1 |
| Tani, T | 1 |
| Toba, Y | 1 |
| Sasabe, H | 1 |
| Nakagiri, N | 1 |
| Hongoh, O | 1 |
| Fujita, S | 1 |
| Akiyama, H | 1 |
| Kudo, S | 1 |
| Shimizu, T | 1 |
7 other studies available for cilostazol and Pregnancy
| Article | Year |
|---|---|
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
Topics: Animals; Anticonvulsants; Anxiety; Autism Spectrum Disorder; Behavior, Animal; Biomarkers; Brain; Ci | 2021 |
Improvement in in vitro fertilization outcome following in vivo synchronization of oocyte maturation in mice.
Topics: Animals; Birth Rate; Cilostazol; Dose-Response Relationship, Drug; Estrus Synchronization; Female; F | 2015 |
Cilostazol blocks pregnancy in naturally cycling swine: An animal model.
Topics: Animals; Cilostazol; Contraceptive Agents, Female; Estrus; Female; Humans; Intermittent Claudication | 2015 |
The role of cilostazol, a phosphodiesterase 3 inhibitor, on oocyte maturation and subsequent pregnancy in mice.
Topics: Animals; Cells, Cultured; Cilostazol; Contraceptive Agents, Female; Dose-Response Relationship, Drug | 2012 |
Cilostazol blocks pregnancy in naturally cycling mice.
Topics: Animals; Cilostazol; Contraceptive Agents; Drug Evaluation, Preclinical; Estrous Cycle; Female; Male | 2013 |
General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents; Azoles; Cats; Cilostazol; Digestive System; D | 1985 |
The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man.
Topics: Absorption; Animals; Autoradiography; Azoles; Bile; Blood Proteins; Carbon Radioisotopes; Cilostazol | 1985 |